AI Healthcare Tools tagged target-id

AI-driven drug discovery platform with a knowledge graph and target ID engine. BenevolentAI combines biomedical knowledge graphs with ML to identify novel targets and repurposing opportunities. Partnerships include AstraZeneca and Merck KGaA.

Causal AI platform for drug discovery and precision medicine. BioSymetrics Contingent AI combines biomedical data with causal inference for target ID and patient stratification.

AI biomedical knowledge platform for target discovery and translational research. Causaly extracts causal relationships from biomedical literature to support target ID, biomarker discovery, and competitive intelligence. Customers include AstraZeneca and Novo Nordisk.

Genetics-driven target discovery using ML. Empirico's PIONEER platform mines population genetics for drug targets.

End-to-end generative AI drug discovery from target identification to clinical trials. Insilico's Pharma.AI platform (PandaOmics, Chemistry42, InClinico) covers target discovery, generative chemistry, and trial outcome prediction.